NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Hermann Kreyenberg, Andrea Jarisch, Christina Bayer, Blanca Schuster, André Willasch, Brigitte Strahm, Bernhard Kremens, Bernd Gruhn, André Schrauder, Stefan Burdach, Monika Führer, Claudia Rössig, H. Kabisch, Paul-Gerhard Schlegel, Daniel Stachel, James F. Beck, Christine Mauz‐Koerholz, Tje Lin Chung, Ernst Holler, Thomas Klingebiel, Peter BaderBlood 2011 · DOI · OpenAlex

Abstract

of red cell mass in all patients diagnosed with ET, or indeed how an abnormal result should influence therapy.In the absence of informative clinical studies we take a pragmatic approach and base a diagnosis of PV on the presence of a JAK2 mutation and a raised hematocrit (with or without supporting features such a low serum erythropoietin), an approach consistent with both WHO and BCSH guidelines, 3,4 and we do not measure red cell mass in our ET patients.In the context of hydroxyurea, Drs Spivak and Silver claim that we have misinterpreted the results of the PT-1 trial.This is incorrect.We state that "Hydroxycarbamide (also known as hydroxyurea) is the only cytoreductive agent proven to reduce thrombotic events in a randomized controlled trial" 1p1477 and feel it would be inappropriate to ignore carefully documented transient ischemic attacks given the considerable evidence that they are harbingers of completed strokes. 5Last, Drs Spivak and Silver claim we dismiss evidence that hydroxyurea is leukemogenic.Once again this is wrong.After weighing up the strength of the published evidence and citing multiple papers supporting both sides of this debate, we conclude "At this time it is unclear whether single agent hydroxycarbamide is leukemogenic; however, any increased risk is likely to be small and should be balanced against the reduction in thrombotic complications."1p1478
BibTeX
@inproceedings{kreyenberg2011nod,
  author = {Hermann Kreyenberg and Andrea Jarisch and Christina Bayer and Blanca Schuster and André Willasch and Brigitte Strahm and Bernhard Kremens and Bernd Gruhn and André Schrauder and Stefan Burdach and Monika Führer and Claudia Rössig and H. Kabisch and Paul-Gerhard Schlegel and Daniel Stachel and James F. Beck and Christine Mauz‐Koerholz and Tje Lin Chung and Ernst Holler and Thomas Klingebiel and Peter Bader},
  title = {{NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation}},
  booktitle = {Blood},
  year = {2011},
  doi = {10.1182/blood-2011-05-356451},
}

Loading related content...

Figure